๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Chronic Myelogenous Leukemia

ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants NCT06787144Phase 14 sites๐Ÿ“ Akita๐Ÿ“ Sapporo๐Ÿ“ Suita-shi Enliven Therapeutics ยท Tests: ELVN-001 Pacritinib in CMML NCT06159491Phase 1, Phase 21 site๐Ÿ“ New York Douglas Tremblay ยท Tests: Pacritinib, Azacitidine A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias NCT06994676Phase 111 sites๐Ÿ“ Duarte๐Ÿ“ Palo Alto๐Ÿ“ Tampa Crossbow Therapeutics, Inc. ยท Tests: CBX-250 International Chronic Myeloid Leukemia Pediatric Study NCT01281735n/a20 sites๐Ÿ“ North Adelaide๐Ÿ“ Vienna๐Ÿ“ Minsk Poitiers University Hospital TGRX-678 US Phase I for Chronic Myelogenous Leukemia Patients NCT06088888Phase 12 sites๐Ÿ“ Houston๐Ÿ“ Seattle Shenzhen TargetRx Co., Ltd. ยท Tests: TGRX-678 Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations NCT07143669n/a26 sites๐Ÿ“ Birmingham๐Ÿ“ Birmingham๐Ÿ“ Scottsdale Blueprint Medicines Corporation ยท Tests: Screening Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen NCT06532084Phase 21 site๐Ÿ“ Saint Petersburg St. Petersburg State Pavlov Medical University ยท Tests: Sorafenib Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China NCT07375355n/a1 site๐Ÿ“ Wuhan Novartis Pharmaceuticals Impact of Targeted Therapy on Cancer-Related Cognitive Impairment NCT07638007n/a1 site๐Ÿ“ Rochester University of Rochester NCORP Research Base A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) NCT01351545n/a142 sites๐Ÿ“ Birmingham๐Ÿ“ Gilbert๐Ÿ“ Phoenix Center for International Blood and Marrow Transplant Researโ€ฆ ยท Tests: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor NCT07238712Phase 21 site๐Ÿ“ Saint Petersburg St. Petersburg State Pavlov Medical University ยท Tests: Ruxolitinib, Abatacept (Orencia) A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy NCT07091019n/a17 sites๐Ÿ“ Birmingham๐Ÿ“ Stockton๐Ÿ“ Torrance Novartis Pharmaceuticals ยท Tests: TKIs Olverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CML NCT06757855Phase 1, Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Olverembatinib, Venetoclax, Azacitidine A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany NCT07549516n/a69 sites๐Ÿ“ Baden-Baden๐Ÿ“ Heidenheim๐Ÿ“ Schwรคbisch Hall Novartis Pharmaceuticals Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia NCT06629584Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Asciminib Efficacy and Safety of Generic Imatinib (Carcemiaยฎ) Compared to Glivecยฎ in Real-Life Management of Chronic Phase of Chronic Myeloid Leukemia NCT05282108n/a4 sites๐Ÿ“ Cairo๐Ÿ“ Cairo๐Ÿ“ Cairo Hikma Pharmaceuticals LLC ยท Tests: Carcemia, Glivec Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: biologic sample preservation procedure, cytology specimen collection procedure Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia NCT03418038Phase 24 sites๐Ÿ“ Mankato๐Ÿ“ Rochester๐Ÿ“ Eau Claire Mayo Clinic ยท Tests: Ascorbic Acid, Carboplatin, Cisplatin, Cytarabine, Dexamethasone CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant NCT06059391Phase 23 sites๐Ÿ“ Duarte๐Ÿ“ Atlanta๐Ÿ“ Boston City of Hope Medical Center ยท Tests: Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Granulocyte Colony-Stimulating Factor, Hemaโ€ฆ Study of Olverembatinib (HQP1351) in Patients With CML-CP NCT06423911Phase 3163 sites๐Ÿ“ Birmingham๐Ÿ“ Anchorage๐Ÿ“ Goodyear Ascentage Pharma Group Inc. ยท Tests: olverembatinib, Bosutinib Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia NCT07071155EARLY Phase 11 site๐Ÿ“ Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: Momelotinib, Azacitidine Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia NCT07588594NA1 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: TBF regimen Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL NCT04260022Phase 19 sites๐Ÿ“ Birmingham๐Ÿ“ Duarte๐Ÿ“ Atlanta Ascentage Pharma Group Inc. ยท Tests: Ascentage Pharma HQP1351 bioavailable inhibitor, Blinatumomab Asciminib RMP Study NCT05943522n/a17 sites๐Ÿ“ Wลnju๐Ÿ“ Anyang-si๐Ÿ“ Bucheon-si Novartis Pharmaceuticals ยท Tests: Asciminib Second STOP After Pioglitazone Priming in CML Patients NCT02889003Phase 26 sites๐Ÿ“ Le Chesnay๐Ÿ“ Le Kremlin-Bicรชtre๐Ÿ“ Lyon Versailles Hospital ยท Tests: Pioglitazone + TKI Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome NCT02269592n/a7 sites๐Ÿ“ Boston๐Ÿ“ Brighton๐Ÿ“ Methuen Dana-Farber Cancer Institute A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia NCT07061145n/a1 site๐Ÿ“ Reggio Emilia Azienda USL Reggio Emilia - IRCCS ยท Tests: Tirosin Kinase Inhibitors Personalized NK Cell Therapy in CBT NCT02727803Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Allogeneic Natural Killer Cell Line NK-92, Anti-Thymocyte Globulin, Busulfan, Clofarabine, Cyclophosphamide Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS NCT04708054Phase 2, Phase 31 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Busulfan, Cladribine, Fludarabine Phosphate, Hematopoietic Cell Transplantation, Thiotepa A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant NCT07020533Phase 13 sites๐Ÿ“ Duarte๐Ÿ“ Atlanta๐Ÿ“ Boston City of Hope Medical Center ยท Tests: Biospecimen Collection, Electronic Health Record Review, Haploidentical Hematopoietic Cell Transplantation, Letermovir,โ€ฆ
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy